Diabetes complications: Semaglutide probably carries a much higher risk of neovascular age-related ma

GLP-1 receptor agonists Diabetes complications: Semaglutide likely carries a much higher risk of neovascular age-related macular degeneration

According to a Canadian study, patients with diabetes taking semaglutide appear to have more than double the risk of neovascular age-related macular degeneration. The duration of treatment also appears to be relevant.